Physician perspectives on reducing harm and supporting emergency department patients who use drugs
Zoe K. D. Collins,Elaine Hyshka,Karine J. Lavergne,Savannah M. Weber,Ginetta Salvalaggio,Cindy Jiaxin Xue,Arlanna Pugh,Janusz Kaczorowski,Aaron M. Orkin,Andrew Kestler,Kathryn A. Dong, PLoS One
Comparative Effectiveness of Buprenorphine/Naloxone and Methadone on Methamphetamine/Amphetamine Use Among People with Opioid Use Disorder in Canada
Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Socías ME., Subst Use Addctn J. 2025
Scapegoated communities, shared struggles: A call for solidarity with people who use drugs and queer and trans people
Kira London‑Nadeau, Christian Barborini, Rebecca Haines‑Saah, Misha Bazarov, Sean Bristowe, Misha Khorkhordina, Mélodie Lemay‑Gaulin, Catherine Gorka, Robert‑Paul Juster, Heath D’Alessio, Nicholas Chadi, International Journal of Drug Policy, 2025
The erosion of safer supply programs in Ontario, Canada: A dangerous step backward
Ali, F., Sprakes, A., Mende-Gibson, J., Russell,C., Shaw, A., Bonn, M., Celinski, A., Kaminski, N., Karamouzian, M., Strike, C., Rhem, J., Drug Science, Policy and Law
Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada
Mayer S, Fairbairn N, Fowler A, Boyd J, Kerr T, McNeil R., Harm Reduct J. 2025
Applying a Modified Version of the Prediction of Alcohol Withdrawal Severity Scale in a Canadian Community Withdrawal Management Setting
Crepeault H, Cowan N, Socias ME, Riazi N, Knill A, Khela A, Wood E, Ti L., Drug Alcohol Rev. 2025
Intravenous Fentanyl for Symptom Management in Hospitalized Patients With Refractory Opioid Withdrawal: A Retrospective Cohort Study
Zazoulina J, Nolan S, Fairbairn N, Ryan A, Dennis BB, Bach P., J Addict Med. 2025
Exploring Pain‑Severity and Psychological‑Flexibility Trajectories During Group‑Based Psychotherapy for Chronic Pain
Élisabeth Lamoureux, Karen Ghoussoub, Yoram Shir, Marc O. Martel, Zakhar Prylutskyy, M. Gabrielle Pagé, International Journal of Group Psychotherapy, 2025
Primary care physician characteristics associated with becoming opioid agonist treatment prescribers in British Columbia: a retrospective case‑control study
Dimitra Panagiotoglou, Sandra Peterson, M. Ruth Lavergne, Tara Gomes, Rashmi Chadha, Cheyenne Johnson, Rita McCracken, Harm Reduction Journal, 2025
Harm reduction in photovoice knowledge mobilization with 2S/LGBTQ+ youth who use(d) drugs: A community showcase
Goodyear T, Barborini C, Gilmore R, Collin-Gray A, Jensen M, Young L, Hossain A, He E; Other Members of the Substance Use Beyond the Binary Youth Action Committee., Harm Reduct J. 2025
